SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-008747
Filing Date
2021-05-04
Accepted
2021-05-04 07:38:25
Documents
16
Period of Report
2021-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lnth-20210504.htm   iXBRL 8-K 36876
2 EX-99.1 exhibit991q12021earningspr.htm EX-99.1 181208
8 lantheusa111.jpg GRAPHIC 6525
  Complete submission text file 0001628280-21-008747.txt   384493

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lnth-20210504.xsd EX-101.SCH 2423
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lnth-20210504_cal.xml EX-101.CAL 710
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lnth-20210504_def.xml EX-101.DEF 1643
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lnth-20210504_lab.xml EX-101.LAB 23970
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lnth-20210504_pre.xml EX-101.PRE 12646
9 EXTRACTED XBRL INSTANCE DOCUMENT lnth-20210504_htm.xml XML 11419
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36569 | Film No.: 21886018
SIC: 2835 In Vitro & In Vivo Diagnostic Substances